NCT02790580

✓ Unanimous Initial: other Requery: other — This is a chemotherapy trial conducted at an outpatient cancer center where patients receive IV infusions and oral medications as outpatients, not as hospitalized inpatients. Thinking: other — The intervention involves chemotherapy infusions administered every 2 weeks without requiring hospitalization, indicating outpatient clinic delivery.

✓ Unanimous Initial: hospital Requery: hospital — The intervention involves dose-dense chemotherapy requiring administration in a clinical setting with access to treatment for side effects like myelosuppression, often provided in a hospital-based setting. Thinking: other — Chemotherapy and oral sunitinib are given in an outpatient cancer clinic (no inpatient admission required), so it is not classified as hospital-based inpatient care.

✓ Unanimous Initial: other Requery: other — The chemotherapy is delivered in an outpatient or ambulatory care setting every 2 weeks, rather than requiring continuous inpatient hospital admission.